Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes

Keyphrases

• Abdominal Imaging 14%
• Acceptable Risk 14%
• Active Surveillance 100%
• Aggressiveness 14%
• Angiomyolipoma 14%
• Benign Tumor 14%
• Cancer Mortality 14%
• Clinical Outcomes 100%
• Clinical Predictors 14%
• Clinically Localized 100%
• Comorbid Patients 14%
• Competing Causes 14%
• CT1b 14%
• Disease Progression 14%
• Disease Risk 14%
• Disease-specific Mortality 14%
• Elderly Patients 14%
• Expectant Management 28%
• Histological Characterization 14%
• Informed Patient 14%
• Localized Kidney Cancer 100%
• Long Follow-up 14%
• Long-term Oncological Outcomes 14%
• Metastatic Potential 14%
• Overtreatment 14%
• Patient Selection 42%
• Proof of Safety 14%
• Renal Tumor 28%
• Renal Tumor Biopsy 14%
• Review Update 100%
• Short Life Expectancy 14%
• Small Renal Mass 42%
• Surveillance Protocol 28%
• Tumor 42%
• Tumor Growth Rate 14%

Medicine and Dentistry

• Abdominal Imaging 14%
• Angiomyolipoma 14%
• Benign Tumor 14%
• Cause of Death 14%
• Clinical Predictor 14%
• Disease Exacerbation 14%
• Kidney Tumour 100%
• Life Expectancy 14%
• Malignant Neoplasm 14%
• Metastasis Potential 14%
• Neoplasm 42%
• Patient Selection 14%
• Prospective Study 14%
• Tumor Biopsy 14%
• Tumor Progression 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiomyolipoma 14%
• Benign Neoplasm 14%
• Cause of Death 14%
• Disease Exacerbation 14%
• Kidney Tumour 100%
• Life Expectancy 14%
• Malignant Neoplasm 14%
• Metastasis Potential 14%
• Neoplasm 42%
• Prospective Study 14%
• Tumor Growth 14%